Safety of immunization and adverse events following vaccination against hepatitis B.
Duclos
Philippe
P
Immunization Safety Priority Project, Department of Vaccines and Biologicals, Health Technology and Pharmaceuticals, World Health Organization, 20 Avenue Appia, CH-1211 Geneva 27, Switzerland. duclosp@who.int
D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D006801:Humans; D007114:Immunization / Q000009:adverse effects*; D014611:Vaccination / Q000009:adverse effects*; D014614:Vaccines, Synthetic / Q000627:therapeutic use
D017325:Hepatitis B Vaccines; D014614:Vaccines, Synthetic